Murray B Resnick Selected Research

Murray B Resnick Research Topics

Disease

51	Neoplasms (Cancer) 02/2022 - 04/2002
13	Carcinoma (Carcinomatosis) 01/2017 - 09/2002
11	Adenocarcinoma 02/2022 - 09/2004
11	Breast Neoplasms (Breast Cancer) 11/2019 - 11/2006
9	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 01/2008
8	Colonic Neoplasms (Colon Cancer) 08/2014 - 05/2004
6	Stomach Neoplasms (Stomach Cancer) 02/2022 - 08/2005
6	Neoplasm Metastasis (Metastasis) 01/2020 - 04/2002
5	Carcinogenesis 01/2020 - 08/2005
5	Eosinophilic Esophagitis 01/2018 - 12/2007
3	Infections 10/2019 - 07/2008
3	Ductal Carcinoma 01/2019 - 04/2013
3	Inflammation (Inflammations) 10/2017 - 01/2012
3	Microsatellite Instability 01/2017 - 08/2012
3	Medullary Carcinoma 01/2016 - 03/2009
3	Renal Cell Carcinoma (Grawitz Tumor) 06/2015 - 11/2008
3	Disease Progression 08/2014 - 04/2005
3	Testicular Neoplasms (Testicular Cancer) 12/2003 - 09/2002
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 05/2009
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2017 - 05/2009
2	Adenocarcinoma of Lung 01/2016 - 12/2010
2	Adenoma (Adenomas) 04/2015 - 01/2010
2	Gastroesophageal Reflux (GERD) 06/2014 - 12/2007
2	Oxyphilic Adenoma (Oncocytoma) 11/2011 - 11/2008
2	Barrett Esophagus (Barrett's Esophagus) 10/2011 - 10/2008
2	Lung Neoplasms (Lung Cancer) 12/2009 - 05/2009
1	Inborn Genetic Diseases (Disease, Hereditary) 02/2022
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2019
1	Residual Neoplasm 01/2018
1	Triple Negative Breast Neoplasms 01/2018
1	Substance-Related Disorders (Drug Abuse) 03/2017
1	Ulcer 01/2017
1	Genetic Translocation (Chromosomal Translocation) 01/2016

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 05/2020 - 07/2003
11	Biomarkers (Surrogate Marker)IBA 01/2018 - 05/2004
9	Messenger RNA (mRNA)IBA 08/2014 - 09/2004
8	Estrogen ReceptorsIBA 11/2019 - 11/2006
6	ParaffinIBA 11/2011 - 05/2004
5	CollagenIBA 02/2022 - 07/2003
5	ErbB Receptors (EGF Receptor)IBA 04/2016 - 05/2004
4	AntigensIBA 10/2019 - 09/2002
3	Progesterone Receptors (Progesterone Receptor)IBA 11/2019 - 12/2009
3	Cadherins (E-Cadherin)IBA 06/2015 - 06/2013
3	Enterotoxin ReceptorsIBA 08/2014 - 01/2010
3	MicroRNAs (MicroRNA)IBA 08/2014 - 12/2010
3	SteroidsIBA 05/2013 - 11/2006
3	Claudin-1IBA 04/2013 - 04/2005
3	ClaudinsIBA 04/2013 - 08/2005
3	Claudin-4IBA 04/2013 - 04/2005
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 11/2011 - 01/2007
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2011 - 04/2003
3	Monoclonal AntibodiesIBA 03/2010 - 03/2003
3	Transcription Factors (Transcription Factor)IBA 12/2009 - 05/2006
2	Carrier Proteins (Binding Protein)IBA 01/2020 - 11/2019
2	Peptides (Polypeptides)IBA 01/2020 - 01/2008
2	ElastinIBA 01/2020 - 01/2019
2	Collagen Type XIBA 11/2019 - 01/2019
2	Anaplastic Lymphoma KinaseIBA 01/2019 - 01/2016
2	RNA (Ribonucleic Acid)IBA 10/2017 - 01/2017
2	Calbindin 2IBA 12/2013 - 03/2009
2	Phenobarbital (Luminal)FDA Link 12/2013 - 04/2013
2	CytokinesIBA 10/2013 - 05/2006
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 10/2013 - 05/2008
2	AcidsIBA 05/2013 - 10/2011
2	Claudin-3IBA 04/2013 - 11/2008
2	claudin 8IBA 04/2013 - 11/2008
2	AntibodiesIBA 02/2013 - 03/2010
2	Formaldehyde (Formol)FDA Link 11/2011 - 12/2007
2	aspartic acid 2-oxoglutarate-dependent dioxygenaseIBA 05/2009 - 01/2007
2	Indicators and Reagents (Reagents)IBA 10/2007 - 04/2005
2	Malondialdehyde (Propanedial)IBA 09/2006 - 09/2004
2	Uncoupling Protein 2IBA 05/2006 - 09/2004
1	Tryptophan-tRNA LigaseIBA 05/2020
1	Immunologic Factors (Immunomodulators)IBA 05/2020
1	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2020
1	EnzymesIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Keratin-7 (Cytokeratin 7)IBA 11/2019
1	Keratins (Keratin)IBA 11/2019
1	Urea (Carbamide)FDA LinkGeneric 10/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	Calcibiotic Root Canal SealerIBA 01/2019
1	human ERBB2 proteinIBA 01/2019
1	ClusterinIBA 01/2018
1	Chemotactic FactorsIBA 01/2018
1	Fatty Acid-Binding ProteinsIBA 01/2017
1	InterferonsIBA 01/2017
1	Immunoglobulin G (IgG)IBA 01/2017
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2017
1	Collagen Type III (Type III Collagen)IBA 11/2016
1	ceritinibIBA 01/2016

Therapy/Procedure

13	Therapeutics 02/2022 - 05/2004
5	Drug Therapy (Chemotherapy) 11/2019 - 01/2006
5	Neoadjuvant Therapy 11/2019 - 04/2016
2	Aftercare (After-Treatment) 10/2013 - 05/2013
2	Lasers (Laser) 10/2008 - 01/2006
2	Immunotherapy 12/2003 - 09/2002
1	Precision Medicine 01/2019
1	Hemorrhoidectomy 03/2017
1	Chemoradiotherapy 01/2017